article thumbnail

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

NORML

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 164
article thumbnail

Hemp Litigation: DEA Sued Again

Canna Law Blog

The Canna Law Blog has been writing about the Drug Enforcement Agency’s (DEA) interim final rule (IFR) on hemp since its August publication in the Federal Register: Watch Out! The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. The DEA Does Not Want You To Worry About Its New Hemp Rule.

DEA 94
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Aurum Labs Receives CDPHE Certification and is Poised to be the First DEA Registered Cannabis & Hemp Testing Laboratory in the US

Cannabis Law Report

Aurum Labs ( [link] ) is now certified by the Colorado Department of Public Health and Environment (CDPHE) to conduct hemp compliance testing for manufactured industrial hemp products and is in the final stages of Drug Enforcement Agency (DEA) registration.

DEA 98
article thumbnail

Enforcement or Compliance

Canna Law Blog

The issue of enforcement or compliance is probably the biggest one most states face at the policy level. Today, we’ll look at the argument that a compliance focus is better than an enforcement focus. Despite all of this, some folks seem to think that prohibition and compliance is still the answer. compliance tradeoff.

article thumbnail

FDA Approves CBD-Containing Drug - Will the DEA Finally Step Up?

MJ Business Attorneys

Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. In the recent case Hemp Industries Associations v.

DEA 113
article thumbnail

The Hemp Industry Responds to the DEA Rule With a Lawsuit

Canna Law Blog

On August 21, the Drug Enforcement Agency (the “DEA”) released an Interim Final Rule (the “ Rule ”), which, in part, suggests that in-process hemp extract shall be treated as a schedule I controlled substance during any point at which its THC concentration exceeds 0.3 But some have taken their opposition one step further by suing the DEA.

DEA 62
article thumbnail

DEA Testing Requirement for Hemp Removed by USDA

The Joint Blog

According to the Daily, the testing delay comes after farmers and states alike complained there wouldn’t be enough DEA labs to handle demand. We now better understand how the limited number of DEA-registered labs will hinder testing and better understand the associated costs with disposing of product that contains over 0.3%

DEA 49